Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
ABIN1
21%
Activating mutation
5%
Activation Loop
5%
African American
10%
Anti-inflammatory Drugs
43%
At a Glance
21%
Autoimmune Disease
27%
Autophosphorylation
21%
BAY 11-7082
43%
BI2536
16%
Binding Inhibitor
21%
Binding Protein
23%
Biological Effects
13%
Biomedical Research
10%
Bone Marrow-derived Macrophages
7%
Bromodomain
21%
Bromodomain-containing Protein 4 (BRD4)
5%
C-Jun
5%
Cardiovascular Disease
5%
Caspase-1
8%
Cell Science
10%
Cell Signaling Networks
10%
Checks-and-balances
10%
Chemical Probes
21%
Cholesterol
5%
Chronic Autoimmune Diseases
5%
Chronic Inflammatory Diseases
5%
Clinical Application
5%
Clinical Trials
5%
Co-crystal Structure
5%
Community-based
10%
Control Cell
10%
Covalent Adduct
5%
Deubiquitinase
7%
DFG-out
5%
Dimerization
24%
Disease Development
7%
Dividends
5%
Double-stranded RNA
21%
Drug Class
5%
Drug Development
5%
Drug Target
16%
Endothelial Dysfunction
21%
Epidermis
21%
European American
10%
Family Members
21%
Gene Transcription
26%
Genetic Basis
21%
High Specificity
7%
High-quality Data
7%
Human Genes
10%
HyPer
10%
Hypertension Disease
5%
Hypertension Management
5%
IFN Regulatory Factor
21%
IKK Complex
37%
IKKα
17%
IL-1 Receptor-associated Kinase 1 (IRAK1)
45%
Immune Cells
6%
Immune Disease
21%
Immune System
16%
Immunoblotting
21%
Inflammation
21%
Inflammatory Diseases
27%
Inflammatory Mediator Production
21%
Inhibitory Activity
5%
Innate Immune Response
24%
Interacting Proteins
23%
Interferon Production
21%
Interferon Regulatory Factor 3 (IRF3)
8%
Interferon Regulatory Factor 5 (IRF5)
5%
Interferon-α (IFN-α)
16%
Interleukin-1 Signaling
21%
Interleukin-10
10%
Interleukin-18 (IL-18)
13%
Interleukin-1β
29%
Interleukin-33 (IL-33)
10%
Interleukin-6
6%
IRAK2
21%
Kinase Activation
5%
Kinase Activity
13%
Kinase Drug Discovery
21%
Kinase Function
5%
Kinase Inhibitor
5%
Kinome
5%
Knock-in Mouse Model
23%
Leucine-rich Repeat Kinase 2 (LRRK2)
5%
Ligation
5%
Linear Ubiquitin Chain
8%
Linkage-specific
7%
LRRK2 Inhibitors
5%
Lupus
7%
Lupus Nephritis
21%
Macrophages
9%
MAP3K7
5%
MAP4K2
21%
MAPK14
5%
Mechanistic Insight
10%
Methionine
21%
Microbial Pathogens
10%
Misinterpretation
7%
Mitogen-activated Protein Kinase
31%
Molecular Control
21%
Molecular Understanding
10%
MyD88 Signaling
7%
MyD88-dependent
26%
Myeloid Cells
32%
Nephritis
10%
NG25
5%
NLRP3 Inflammasome
21%
NOD-like Receptor Protein 3 (NLRP3)
8%
Nuclear factor-B
20%
Nuclear factor-κB
21%
Nuclear Translocation
27%
Optimization Methods
21%
OSR1
5%
Out-of-control
10%
Parkinson's Disease
5%
Pellino-1
21%
Pharmaceutical Industry
5%
Pharmacokinetic Properties
5%
Pharmacological Studies
5%
Pharmacophore Model
5%
Phosphorylation
82%
Physiological Role
10%
Plasmacytoid Dendritic Cells
14%
Polyubiquitin
38%
Polyubiquitin Chains
38%
Poor Quality
10%
Posters
10%
Potent Inhibitor
21%
Protein Kinase
74%
Protein Kinase Inhibitors
5%
Protein Linkages
7%
Protein Phosphorylation
10%
Protein Tyrosine Phosphatase 1B (PTP1B)
21%
Protein Tyrosine Phosphatase Inhibitor
5%
Protein Ubiquitylation
18%
Pseudokinase
5%
Pyridine
5%
Pyroptosis
8%
Pyrrol
5%
Recent Advances
10%
Receptor 1
26%
Sample Preparation
7%
Selective Inhibitor
5%
Selectivity Profile
5%
Semi-quantitative Analysis
7%
Sendai Virus
21%
Separate Detection
7%
Separation Identification
7%
Signal Transduction Pathway
9%
Signaling Axis
10%
Signaling Network
78%
Specific Inhibitor
5%
Specific Topic
7%
Speed Sensitivity
7%
Stimulator of Interferon Genes (STING)
30%
Structure-activity Relationship
5%
Systemic Lupus Erythematosus
12%
Target Molecule
5%
Therapeutic Potential
10%
Tissue Damage
10%
TNIP1
7%
Toll-like
72%
Toll-like Receptor 4 (TLR4)
7%
Transcription Factor
14%
Transforming Growth Factor-β
27%
Tumor Necrosis Factor-α
16%
Type II Inhibitor
21%
Tyrosine Kinase
5%
UbcH7
5%
Ubiquitin Chain Topology
7%
Ubiquitin Chains
43%
Ubiquitin Linkage
7%
Ubiquitin Signaling
7%
Ubiquitin System
43%
Ubiquitin-binding Protein
29%
Ubiquitylation
47%
Viral Origin
8%
Wiki-resource
10%
Immunology and Microbiology
Agonist
29%
Autoimmune Disease
28%
Biological Activity
10%
Bone Marrow-Derived Macrophage
10%
Caspase 1
10%
Complement Factor B
12%
Cytokine Production
7%
Dendritic Cell Line
15%
Dimerization
26%
Fibrinogen
21%
Genetic Transcription
26%
Immune Disorder
21%
Immune System
10%
Immunocompetent Cell
6%
Infectious Agent
10%
Innate Immune System
21%
interferon
39%
Interferon Production
21%
Interferon Regulatory Factor 5
8%
Interleukin 1
21%
Interleukin 10
9%
Interleukin 18
13%
Interleukin 33
10%
Interleukin 6
14%
IRAK1
21%
IRF3
8%
Lupus Erythematosus
21%
Macrophage Cell Line
10%
Mediator
21%
Mitogen
9%
Myeloid
32%
Nephritis
21%
NLRP3 Inflammasome
21%
Oligomerization
16%
Plasmacytoid Dendritic Cell
29%
Promoter Region
26%
Protein Phosphorylation
10%
Pyroptosis
8%
Resiquimod
10%
Secretion (Process)
29%
Sendai Virus
21%
Systemic Lupus Erythematosus
11%
TLR 1
21%
TLR3
17%
TLR4
12%
TLR7
8%
TLR9
8%
Toll-Like Receptor
57%
Transcription Factors
24%
Tumor Necrosis Factor
7%
Ubiquitination
21%
Ubiquitins
29%
Vasodilatation
7%
Wild Type
43%
Biochemistry, Genetics and Molecular Biology
Agonist
11%
Autophosphorylation
21%
Binding Protein
26%
Biological Activity
21%
Bromodomain
21%
Cancer Growth Factor
21%
Caspase 1
10%
Complement Factor B
6%
Dimerization
24%
Factor V
21%
Gene Linkage
6%
Genetic Transcription
21%
Immunoblotting
21%
In Vivo Study
25%
Innate Immunity
9%
Interferon
21%
Interleukin 10
7%
Interleukin 6
12%
Interleukin-1
16%
IRAK1
21%
IRAK2
21%
Kinase
63%
Macrophage
16%
MAP Kinase Kinase Kinase
21%
Mediator
21%
Messenger RNA
17%
Methionine
21%
Mitogen-Activated Protein Kinase
10%
Myeloid
23%
NLR Family Pyrin Domain containing 3
8%
NLRP3 Inflammasome
21%
Oligomerization
7%
Phosphotransferase
63%
Plasmacytoid Dendritic Cell
14%
Promoter Region
10%
Protein Kinases
37%
Pyroptosis
8%
Secretion (Process)
17%
TLR4
6%
Toll-Like Receptor
30%
Transcription Factors
10%
Ubiquitin
100%
Ubiquitination
45%
Vasodilatation
7%
Wild Type
26%